May 28th 2024
Relacorilant achieves primary endpoint in phase 3 GRACE trial among patients with hypercortisolism and hyperglycemia, hypertension or both, with sNDA expected in Q3 2024.
Q&A With Paul Gurbel From Inova Health System: Examining the Benefits of Extended Release Aspirin
In the medical community there are many questions about the benefits of patients on a daily aspirin regimen and who should be considered for this treatment option. While these questions apply mainly to standard aspirin treatments currently available there is work being done to move the field in a new direction.
Dementia Risk Increased for Patients with Diabetes
Researchers in China retrospectively studied health records of 430,000 people age 50 years or older who had recently been diagnosed with diabetes to investigate the link between dementia risk and the severity and progression of diabetes.